Investorideas.com newswire, breaking biotechnology and pharma news

Friday, July 26, 2019

Investor Ideas adds New #Stocks in Tech (TSXV: $MTLO.V) (NASDAQ: $JFIN), Biotech (NASDAQ: $OTLK), Green Stocks (NASDAQ: $REAL), Cannabis (CSE: $GRIN.C), Mining (TSXV: $SMN.V) and China-Asia (NASDAQ: $ATIF)

Investor Ideas adds New #Stocks in Tech (TSXV: $MTLO.V) (NASDAQ: $JFIN), Biotech (NASDAQ: $OTLK), Green Stocks (NASDAQ: $REAL), Cannabis (CSE: $GRIN.C), Mining (TSXV: $SMN.V) and China-Asia (NASDAQ: $ATIF)



Point Roberts WA, Delta BC, July 26, 2019 – (Investorideas.com Newswire) Investorideas.com, a global news source and leading investor resource announces this week’s additions to its global stock directories in tech, biotech, green, cannabis, mining and China-Asia.


This week’s new tech companies are involved in software, fintech, AI, cloud, internet websites and social media sites, with a number based in Asia, thus crossing into the China-Asia stocks list.

The latest biotech companies focus on eczema treatment, cardiovascular disease and macular degeneration.

Investor Ideas is currently revising its Environment, Renewable Energy and LOHAS (Lifestyle of Health and Sustainability) stock lists, combining them into one new and comprehensive stock list to be called Green and Eco-Friendly Stocks.  The new list will include a new section;  Health, Wellness and Sustainability Stocks which replaces the LOHAS Stock List and will include this week’s new green stocks - Global Fiber Technologies, Inc. (OTC:GFTX), Code Green Apparel Corp. (OTC:CGAC), The RealReal, Inc. (NasdaqGS:REAL).  The new stock lists will be available for viewing on Monday, July 29 – be sure to check it out!

The newest cannabis companies are involved in a “seed to experience” process which includes resin, carts and chocolate edibles and CBD Pet Health products, respectively.

The latest mining company is TSX Venture listed and has operations in Canada and Mexico and the newest China-Asia company is a financial consulting firm that specializes in assisting China-based companies to go public in the US.

New Tech Companies:
Martello Technologies Group Inc. (TSXV: MTLO.V) is a technology company that provides clarity and control of complex IT infrastructures. The company develops products and solutions that monitor, manage and optimize the performance of real-time applications on networks, while giving IT teams and service providers control and visibility of their entire IT infrastructure. Martello's products include SD-WAN technology, network performance management software, and IT analytics software. Martello Technologies Group is a public company headquartered in Ottawa, Canada with offices in Montreal , Amsterdam , Paris , Dallas and New York .

GlobeX Data Ltd. (CSE: SWIS, SWIS.WT) distributes, designs and develops Swiss hosted software solutions for secure data management and secure communications. The Company distributes a suite of secure cloud-based storage, document management and collaboration, encrypted e-mails, and secure communication tools. GlobeX Data sells its products through distributors and telecommunication companies worldwide. GlobeX Data serves consumers, businesses and governments worldwide.

JIAYIN GROUP INC. (NasdaqGM:JFIN) operates as an online individual finance marketplace that connects individual investors and individual borrowers in China. It operates a secure and open platform that facilitates transparent, secure, and fast connections between investors and borrowers

SO-YOUNG INTERNATIONAL INC. (NasdaqGM:SY) is the most popular online destination for discovering, evaluating and reserving medical aesthetic services in China. With reliable and comprehensive content, as well as a multitude of social functions on its platform, users seeking medical aesthetic treatment can discover products and services, evaluate their quality, and reserve desired treatment. Leveraging So-Young’s strong brand image, extensive audience reach, trust from its users, highly engaging social community and data insights, the Company is well positioned to expand both along the medical aesthetic industry value chain and into the massive, fast-growing consumption healthcare service market.   

LUCKIN COFFEE INC. (NasdaqGS:LK) has pioneered a technology-driven new retail model to provide coffee and other products of high quality, high affordability, and high convenience to its customers. Empowered by big data analytics, AI, and proprietary technologies, the Company pursues its mission to be part of everyone’s everyday life, starting with coffee. The Company was founded in 2017 and is based in China.

GSX TECHEDU INC. (NYSE:GSX) is a technology-driven education company and a leading online K-12 large-class after-school tutoring service provider in China. GSX Techedu offers K-12 courses covering all primary and secondary grades as well as foreign language, professional and interest courses. GSX Techedu adopts an online live large-class format to deliver its courses, which the Company believes is the most effective and scalable model to disseminate scarce high-quality teaching resources to aspiring students in China. Big data analytics permeates each aspect of the Company’s business and facilitates the application of the latest technology to improve teaching delivery, student learning experience, and operational efficiency.

New Biotech Companies:
Outlook Therapeutics, Inc. (NASDAQCM: OTLK) is a late clinical-stage biopharmaceutical company focused on developing ONS-5010, a proprietary ophthalmic bevacizumab product candidate for the treatment of wet age related macular degeneration (wet AMD) and other retina diseases.  ONS-5010 is currently in Phase 3 clinical trials for patients suffering from wet AMD.

Hoth Therapeutics, Inc. (NASDAQCM: HOTH) a Nevada corporation, is a biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications such as atopic dermatitis, also known as eczema. Hoth has exclusive worldwide rights to the BioLexa Platform.

Acasti Pharma Inc. (NASDAQCM:ACST) (TSX: ACST.V) is a biopharmaceutical innovator advancing a potentially best-in-class cardiovascular drug, CaPre® (omega-3 phospholipid), for the treatment of hypertriglyceridemia, a chronic condition affecting an estimated one third of the U.S. population. Since its founding in 2008, Acasti Pharma has focused on addressing a critical market need for an effective, safe and well-absorbing omega-3 therapeutic that can make a positive impact on the major blood lipids associated with cardiovascular disease risk. Acasti Pharma is developing CaPre in a Phase 3 clinical program in patients with severe hypertriglyceridemia, a market that includes 3 to 4 million patients in the U.S. The addressable market may expand significantly if omega-3s demonstrate long-term cardiovascular benefits in on-going third-party outcomes studies. Acasti Pharma may need to conduct at least one additional clinical trial to support FDA approval of a supplemental New Drug Application to expand CaPre’s indications to this segment. Acasti Pharma’s strategy is to commercialize CaPre in the U.S. and Acasti Pharma is pursuing development and distribution partnerships to market CaPre in major countries around the world.

Green Sector Companies:
MGX Renewables Inc. (CSE: MGXR) has assembled an experienced team to execute the development and commercialization of a dependable low-cost zinc-air battery. This mass storage system offers both environmental and efficiency benefits. MGXR strives to meet the growing need for secure and reliable power.

Global Fiber Technologies, Inc. (OTC:GFTX) is a “green” apparel rejuvenation and fiber recovery company utilizing patent pending technology which takes landfill destined corporate uniforms and rejuvenates them into new, great looking uniforms. The company was formerly known as Eco Tek 360, Inc

Code Green Apparel Corp. (OTC:CGAC) designs, manufactures, and distributes apparel products from eco-friendly and sustainable recycled textiles worldwide. It offers uniforms, caps, T-shirts, aprons, polo shirts, hats, pants, shorts, jackets, and accessories. The company was formerly known as J.D. Hutt Corporation

The RealReal, Inc. (NasdaqGS:REAL) is the world’s largest online marketplace for authenticated, consigned luxury goods. We are revolutionizing luxury resale by providing an end-to-end service that unlocks supply from consignors and creates a trusted, curated marketplace for buyers globally. We aggregate and curate unique, pre-owned luxury supply that is exclusive to The RealReal across multiple categories, including women’s, men’s, kids’, jewelry and watches, and home and art. We have built a vibrant marketplace that we believe expands the overall luxury market, promotes the recirculation of luxury goods and contributes to a more sustainable world.

Cannabis Companies:
Grown Rogue International Inc. (CSE:GRIN) (OTC:GRUSF) is a vertically-integrated, multi-state Cannabis family of brands on a mission to inspire consumers to "enhance experiences" through cannabis. We have combined an expert management team, award winning grow team, state of the art indoor and outdoor manufacturing facilities, and consumer insight based product categorization, to create innovative products thoughtfully curated from "seed to experience." The Grown Rogue family of products include sungrown, light dep and indoor premium flower, live rosin jars and terp diamonds, infused, indoor and sungrown pre-rolls, live resin and rosin carts, along with chocolate edibles created in partnership with a world-renowned Chocolatier.

Applied BioSciences Corp. (OTCQB: APPB) is a diversified company focused on multiple areas of the medical, bioceutical and pet health industry. As a leading company in the CBD and Pet health space, the company is currently shipping to the majority of US states as well as to 5 International countries. The company is focused on select investment, consumer brands, and partnership opportunities in the medical, health and wellness, nutraceutical, and media industries.

Mining Companies:
San Marco Resources Inc. (TSXV: SMN.Vis a Canadian mineral exploration company actively pursuing world class gold, silver, zinc and copper projects with a focus on mining friendly jurisdictions in both British Columbia, Canada and Mexico.The Company's principal focus and asset is the recently optioned Buck Property in north-central British Columbia that has large tonnage gold-silver-zinc potential in a mining-friendly region that includes many former and current operating mines. In addition, the Company's portfolio includes the Mexican properties Chunibas, Espiritu SMR, 1068 and Mariana projects in mining-friendly Sonora state while it pursues other district-scale opportunities.

China-Asia Companies:
ATIF Holdings Limited (NasdaqCM:ATIF) is a company providing financial consulting services to small and medium-sized enterprises in Asia. The Company’s core businesses include going public consulting services, international financial consulting services, and financial media services. The Company has advised several enterprises in China to go public in the U.S. At present, the Company has business centers and service centers in Hong Kong and Shenzhen, and a team of experienced consulting professionals. The Company owns www.chinacnnm.com, a news and media website that provides social news and financial information to the Asian region

The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.

About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and  sector trends  from Investorideas.com with our news alerts , articles , podcasts and videos  talking about cannabis,  crypto,  technology including  AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change Podcast and  the AI Eye Podcast and column covering developments in AI. 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Learn more about our news, PR and social media services at Investorideas.com

Follow us on Twitter https://twitter.com/Investorideas

To sponsor a daily podcast for the month or to be an expert guest please contact us!

Contact Investorideas.com
800-665-0411













Friday, July 19, 2019

Investor Ideas Adds Recent IPO’s in #Biotech (NASDAQ: $PSNL) (NASDAQ: $STOK), #Tech (NASDAQ: $SONM) and #Defense (NYSE: $PSN)

Investor Ideas Adds Recent IPO’s in #Biotech
(NASDAQ: $PSNL) (NASDAQ: $STOK), #Tech (NASDAQ: $SONM) and #Defense (NYSE: $PSN)


Point Roberts WA, Delta BC, July 19, 2019 – (Investorideas.com Newswire) Investorideas.com, a global news source and leading investor resource announces this week’s additions to its global stock directories in biotech, tech and defense.


This week’s new additions are all recent Nasdaq IPO’s with the majority in the biotech sector.

New biotech companies include biopharma firms, life sciences companies and drug development companies working on treatments for cancer, diabetes, heart disease, genetic disorders, neurologic disorders and others.

The latest tech companies include a Russian online job recruitment platform and a company designing ultra-rugged mobility solutions.

The newest defense stock, PARSONS CORP. (NYSE:PSN) is a leading provider of tech solutions focused on the defense, intelligence and critical infrastructure markets and is also involved in cyber security solutions, thus crossing over onto the tech sector stock list as well.

New Biotech Companies:
PERSONALIS, INC(NasdaqGM:PSNL) is a growing cancer genomics company transforming the development of next-generation therapies by providing more comprehensive molecular data about each patient’s cancer and immune response. The company’s NeXT™ Platform is designed to adapt to the complex and evolving understanding of cancer, providing its biopharmaceutical customers with information on all of the approximately 20,000 human genes, together with the immune system, from a single tissue sample. The Personalis Clinical Laboratory is GxP aligned as well as CLIA’88-certified and CAP-accredited.

STOKE THERAPEUTICS, INC. (NasdaqGS:STOK) is a biotechnology company that is pioneering a new way to treat the underlying causes of severe genetic diseases by precisely upregulating protein expression to restore target proteins to near normal levels. Stoke aims to develop the first precision medicine platform to target the underlying cause of a broad spectrum of genetic diseases in which the patient has one healthy copy of a gene and one mutated copy that fails to produce a protein essential to health. These diseases, in which loss of approximately 50 percent of normal protein expression causes disease, are called autosomal dominant haploinsufficiencies. Stoke was launched with investments by Apple Tree Partners. Stoke is headquartered in Bedford, Massachusetts with offices in Cambridge, Massachusetts.

APPLIED THERAPEUTICS INC. (NasdaqGM:APLT) is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need. The company’s lead drug candidate, AT-001, is a novel aldose reductase inhibitor (ARI) that is being developed for the treatment of Diabetic Cardiomyopathy, or DbCM, a fatal fibrosis of the heart. The company plans to initiate a Phase 2/3 pivotal study in DbCM in 2019. Applied Therapeutics is also developing AT-007, a central nervous system penetrant ARI, for the treatment of Galactosemia, a rare pediatric metabolic disease, and initiated a Phase 1/2 clinical trial in June 2019. The preclinical pipeline also includes AT-003, an ARI designed to cross through the back of the eye when dosed orally, for the treatment of diabetic retinopathy, expected to advance into a Phase 1 study in 2020.
         
MILESTONE PHARMACEUTICALS INC. (NasdaqGS:MIST) headquartered in Montreal, Canada with a U.S. subsidiary in Charlotte, N.C., is a Phase 3 clinical-stage biopharmaceutical company dedicated to developing and commercializing the investigational new drug etripamil for the treatment of cardiovascular indications. Etripamil is a novel, potent and short-acting calcium channel blocker designed by Milestone and being developed as a rapid-onset nasal spray to be administered by the patient to terminate episodes of paroxysmal supraventricular tachycardia (PSVT) as they occur.  

NEXTCURE, INC. (NasdaqGS:NXTC) is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases. Through our proprietary FIND-IO™ platform, we study various immune cells to discover and understand targets and structural components of immune cells and their functional impact in order to develop immunomedicines. Our initial focus is to bring hope and new treatments to patients who do not respond to current cancer therapies, patients whose cancer progresses despite treatment and patients with cancer types not adequately addressed by available therapies.

AXCELLA HEALTH INC. (NasdaqGM:AXLA) is designing and developing AXA Candidates, compositions of endogenous metabolic modulators, or EMMs, engineered in distinct ratios, designed to target and maximize the fundamental role that EMMs play in regulating multiple metabolic functions. Axcella’s AXA Candidates are generated from its proprietary, human-focused AXA Development Platform. Axcella believes its expertise and capabilities in EMMs position it to become a preeminent biotechnology company reprogramming metabolism to address a diverse set of complex diseases and support health. Axcella’s AXA Development Platform has already produced a pipeline of product candidates in programs targeting liver, muscle and blood. Axcella was founded by Flagship Pioneering.

CORTEXYME, INC. (NasdaqGS:CRTXis a clinical stage biopharmaceutical company pioneering a novel disease-modifying therapeutic approach to treat a key underlying cause of Alzheimer’s disease and other degenerative diseases. Cortexyme is targeting a specific, infectious pathogen found in the brain of Alzheimer’s patients and tied to neurodegeneration and neuroinflammation in animal models. The company’s lead investigational medicine, COR388, is the subject of the GAIN trial, an ongoing Phase 2/3 clinical study in patients with mild to moderate Alzheimer’s disease.
                             
TREVI THERAPEUTICS, INC. (NasdaqGM:TRVI) is a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER to treat serious neurologically mediated conditions. Trevi is currently developing nalbuphine ER for the treatment of chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis (IPF) and levodopa-induced dyskinesia (LID) in patients with Parkinson’s disease. These conditions share a common pathophysiology that is mediated through opioid receptors in the central and peripheral nervous systems. Trevi is currently conducting a Phase 2b/3 clinical trial of nalbuphine ER, referred to as the PRISM trial, in patients with severe pruritus associated with prurigo nodularis.

AVANTOR, INC. (NYSE:AVTR) is a leading global provider of mission critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. We operate in more than 30 countries and deliver an extensive portfolio of products and services. We set science in motion to create a better world.
         
TRANSMEDICS GROUP, INC. (NasdaqGM:TMDXis the world’s leader in portable ex-vivo warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung and liver failure.

New Tech Companies:
HEADHUNTER GROUP PLC (NasdaqGS:HHR) is the leading online recruitment platform in Russia and CIS focusing on facilitating the recruitment process and connecting millions of job seekers with hundreds of thousands of employers annually. HeadHunter is one of the most visited job and employment website globally, our CV database contains 36.2 million CVs and our platform hosts a daily average of more than 559,000 job postings.

SONIM TECHNOLOGIES INC (NasdaqGM:SONM) s a leading U.S. provider of ultra-rugged mobility solutions designed specifically for task workers physically engaged in their work environments, often in mission-critical roles. The Sonim solution includes ultra-rugged mobile phones, a suite of industrial-grade accessories, and data and workflow applications which are collectively designed to increase worker productivity, communication and safety on the job site.

New Defense Companies:
PARSONS CORP. (NYSE:PSN) is a leading provider of technology-driven solutions focused on the defense, intelligence, and critical infrastructure markets. Celebrating 75 years of operations, Parsons provides technical design and engineering services and software products to address our customers' challenges. Parsons has differentiated capabilities in cybersecurity, intelligence, missile defense, space, connected communities, physical infrastructure, and mobility solutions. Parsons' combination of talented professionals and advanced technology enables a safer, smarter, and more interconnected world.

The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.

About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and  sector trends  from Investorideas.com with our news alerts , articles , podcasts and videos  talking about cannabis,  crypto,  technology including  AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change Podcast and  the AI Eye Podcast and column covering developments in AI. 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Learn more about our news, PR and social media services at Investorideas.com

Follow us on Twitter https://twitter.com/Investorideas

To sponsor a daily podcast for the month or to be an expert guest please contact us!

Contact Investorideas.com
800-665-0411